IONIS PHARMACEUT reported $2.2B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 832.77M 47.84M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 1.4M
Arrowhead Research ARWR:US USD 575M 169.7M
Astellas Pharma 4503:JP JPY 1.07T 13.45B
Biomarin Pharmaceutical BMRN:US USD 2.75B 68.76M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Esperion Therapeutics ESPR:US USD 246.68M 15.1M
Exelixis EXEL:US USD 1.62B 222.86M
Halozyme Therapeutics HALO:US USD 739.01M 85.81M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Mirati Therapeutics MRTX:US USD 1.11B 116.82M
Moderna Inc MRNA:US USD 13.43B 866M
Nektar Therapeutics NKTR:US USD 545.97M 53.52M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Novartis NOVN:VX USD 36.91B 44M
Omeros OMER:US USD 443.24M 154.69M
Ptc Therapeutics PTCT:US USD 693.78M 176.52M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 33.82B 3.5B
Sarepta Therapeutics SRPT:US USD 2.56B 68.07M
Ultragenyx Pharmaceutical RARE:US USD 883.9M 128.77M
Vertex Pharmaceuticals VRTX:US USD 12.68B 410.3M